DOD FY12 Lung Cancer Translational Research Partnership Award

Post Date

April 17th 2012

Application Due Date

September 20th 2012

Funding Opportunity Number

W81XWH-12-LCRP-TRPA

CFDA Number(s)

12.420

Funding Instrument Type(s)

Cooperative Agreement
Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

3

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $4320000

• Award Range:

  $None - $None

Grant Description

The key initiative of the Lung Cancer Research Program Translational Research Partnership Award is to encourage partnerships between clinicians and laboratory scientists that will accelerate the movement of promising ideas in lung cancer into clinical applications. This award supports the development of translational research collaborations between two independent, faculty level (or equivalent) investigators to address a central problem or question in lung cancer in a manner that would be less readily achievable through separate efforts. One partner in the collaboration must be a laboratory scientist and the other must be a clinician, and it should be clear that both have had equal intellectual input into the design of the research project. Multi-institutional partnerships are encouraged but not required. At least one member of the partnership must have experience either in lung cancer research or lung cancer patient care. A proposed project in which the clinical partner merely supplies tissue samples or access to patients will not meet the intent of this award mechanism. Submissions from and partnerships with investigators at Military Medical Treatment Facilities, military labs, the Department of Veterans Affairs Medical Centers and research laboratories, and commercial organizations are encouraged. This mechanism does not support clinical trials, but may support correlative studies that are associated with an existing clinical trial and projects that develop clinical endpoints for clinical trials. Research projects may also include preclinical studies in animal models and human subjects and human anatomical substances. Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be in lung cancer.

Contact Information

• Agency

  Department of Defense

• Office:

  Dept. of the Army -- USAMRAA

• Agency Contact:

  PA HELP and eReceipt HELP: 301-682-5507; help@cdmrp.org

• Agency Mailing Address:

  CDMRP Help Desk

• Agency Email Address:

  help@cdmrp.org